"Lorista": umarnin don amfani, farashi da kuma sake dubawa. Analog na analog mai suna "Lorists"

Domin a kara zurfafa rayuwar dan Adam, masana masana kimiyya na WHO sun tayar da hankali don magance cututtuka na zuciya. Abubuwan da sukafi dacewa daga jerin su shine hauhawar jini. Yana haifar da lalacewar ganuwar tasoshin jiki duka. Wannan yana jin dadin zuciya a kwakwalwa, zuciya, kodan da kuma dakatarwa. Saboda haka, hauhawar jini yana haifar da cututtuka masu tsanani, kai tsaye ƙãra yawan mutuwar mutane. Har ila yau, saboda high jini rage ingancin marasa lafiya 'rayuwarsu.

Tunda a cikin zamani na zamani, tsinkaye rayuwa da ingancinsa suna da muhimmanci, to, hawan jini ya kamata a sarrafa shi, ba tare da karuwa mai karfi da karuwa ba. Ana samun wannan ta hanyar amfani da nau'o'i na kwayoyi masu yawa: Masu hana ACE, masu jefa kuri'a na masu karɓan sa, masu sintiri na calcium tare da adrenoblockers da diuretics. Wadannan abubuwa sune tushen tushen maganin hauhawar jini. Kuma miyagun ƙwayoyi "Lorista", analogs da maye gurbin, da abubuwa masu kama da haka, sun kasance masu tasiri, masu tasiri da magungunan gargajiya.

Yanayin gaba na shiri

Magungunan miyagun kwayoyi "Lorista", wanda aka maye gurbinsa a cikin kundin magungunan antihypertensive, ya ƙunshi losartan. Wannan miyagun ƙwayoyi ne mai kwakwalwa mai kwakwalwa na angiotensin II. Hanyoyin da ke tattare da maganin warkewa shi ne hana ƙin angiotensin zuwa mai karɓa na endothelial na jirgin ruwan, wanda ke nuna rashin yiwuwar kwangila. Tsarin dakawar ba ta ƙara ba, amma ya kasance a matakin farko. Wannan shiri ne kamfanin Kamfanin Slovenia KRKA ya yi.

Abin lura shi ne cewa "Lorista" - shi ne Generic, da kuma asali losartan ne 'Cozaar'. Amma wannan ƙwayar ƙwayar lafiya ne na musamman, saboda kamfanin da yake kulawa game da siffarsa mai kyau. An tabbatar da wannan ta hanyar binciken nazarin halittun "Kozaar" da "Loristas", wanda ya tabbatar da tasirin wannan karshen tare da izinin da ya dace.

Umurnai don amfani

An kai wa likitancin likita "Lorista", nazarin magunguna da kwararrun likitoci, da kuma gwaji na asibiti ya tabbatar da tasiriyar miyagun ƙwayoyi a maganin hauhawar jini. Kuma al'ada ne cewa mafi girma nasarar farfadowa zai yiwu idan an tabbatar da shawarwarin da aka tsara a cikin umarnin don amfani. Daga cikin abubuwan da aka tanadar, an nuna maki masu zuwa:

• Alamun hanyoyi masu yawa;

• Tsarin gyaran yanayi da zaɓi na zabin abu;

• Yanayin liyafar;

• Contraindications;

• Tsanani.

Ga kowane tsari na umarnin don amfani, karanta a ƙasa.

Alamomi

Dole ne a yi la'akari da alamomi a cikin umarnin da aka rufe, inda aka nuna su a cikin jerin. Makasudin wannan littafin shine warewar windows don amfani da miyagun ƙwayoyi. Saboda haka, "Lorista" ana amfani dasu don maganin cutar ta jini na farko a cikin kwayar halitta da kuma ci gaban ƙwayar zafi don amsawa wajen shan magunguna daga ƙungiyar masu hana ACE. Anyi la'akari da wannan karshen, yayin da "Losartan" ya zama madadin su a cikin ci gaba da tasiri daga amfani.

Na biyu nuni shine lura da hauhawar jini na haɗari a hade da kuma marasa lafiya tare da babban cututtukan jini. A nan, da aikace-aikace ne ma iyakance yiwuwar illa a kan ACE hanawa. Idan babu sakamako a gefe, to ba daidai ba ne don yin amfani da "Lozartan" da sauran masu satar masu karɓa na angiotensin, amma masu haɗin enzyme.

"Likita" an nuna shi ne don maganin cututtukan zuciya a wasu marasa lafiya wadanda suka ga mafita daga cutar rashin lafiyar cutar daga magunguna da masu haɗarin enzyme. Har ila yau, a gaban ciwon sukari "Lozartan", farashin abin da yake da ƙananan ƙananan, shine miyagun ƙwayoyi. Duk da haka, wannan zai yiwu tare da rashin haƙuri ga masu hana masu kariya na ACE, wanda ya rasa aiki ta hanyar aiki da kuma jigon farawar sakamako na antihypertensive.

Tsarin tsari da kuma zaɓi na zabin

Duk wani analog na "Lorist" an zaɓa na musamman ɗayan ɗayan. Babu kuma kawai bazai iya wanzuwar dangantaka tsakanin matsayi na hauhawar jini da sashi na miyagun ƙwayoyi ba. Akwai wasu lokuta da ke da alaka da ƙananan ƙwayar cuta. Tare da hauhawar jini na digiri na farko tare da haɗarin cutar na zuciya mai tsanani, yana yiwuwa a rubuta 12.5 ko 25 MG na "Lista" kowace rana. Tare da kara digiri na hauhawar jini, sashi yana ƙaruwa.

Maganin miyagun ƙwayoyi "Lozartan" - wannan shi ne mafi muhimmanci mahimmanci a zabar wani takamaiman sunan kasuwanci. Kadai kawai yana da mahimmanci. Kuma zai iya kai har zuwa 200 MG kowace rana, raba zuwa kashi biyu. Sakamakon yin tasirin magani yana da matukar gamsuwa da cutar karfin jini. Yayin da karfin jini ba ya tashi sama da 140, wannan sashi ya isa ga farfadowa.

A cikin yanayin ci gaban CHF da rashin hauhawar jini, haɗar wani mai hana ACE ko ARB yana da mahimmanci don kawar da matakai na fibrosis na myocardial. A wannan yanayin, ana amfani da miyagun ƙwayoyi a matsakaicin magani. An titrated bisa ga matakan matsa lamba, saboda kada ta fada a kasa 110.

Hanyoyin Gaba

Maganin miyagun ƙwayoyi "Lorista" yana rinjayar hanyoyin da ke tattare da kwayoyin halitta na matsa lamba, saboda haka yana da wasu tasiri. Wasu daga cikinsu kuma suna haifar da cututtuka akan hanta, tsarin hematopoiesis. Yawancin lokaci, abin da yake shafi kimanin 1.7% na marasa lafiya, sakamakon illa ne kamar haka: ciwo a cikin ƙananan ciki, gajiya da rauni, ci gaban harsashi na fuska da ƙwayoyi. Don kwatanta, da abin da ya faru na placebo martani ma'ana da mita daga wadannan illa, saboda abin da shiri an dauki mafi aminci yanaye.

"Likita" yana da mahimmanci, wato, a cikin kashi 1 cikin dari, yana haifar da karuwar zuciya. 2% na marasa lafiya suna nuna damuwa kan ci gaba da zawo bayan shan magani "Losartan". Farashin irin wannan la'akari yana da ragu, saboda yawancin waɗannan lokuta ne kadan. Ta hanyar, ko da ba tare da miyagun ƙwayoyi ba, amma saboda matsin da zazzabi na placebo da dyspepsia ya ci gaba a 1.9% na marasa lafiya.

Da wuya, a kalla 1 da 100 marasa lafiya lura bayyanar tsoka zafi, ciwon baya, ci gaban da tsoka cramps. Wannan yanayin ba a ƙayyade shi ba ne don amfani da amfani da Lozartan. Wannan ba wani abu ne kawai ba, wanda aka lura a cikin ƙungiyar kwatanta. An magance lafiyar miyagun ƙwayoyi, wanda ya fi sauƙi fiye da Lorista N da Lorista ND, saboda abubuwan da suka shafi haɗin sun hada da waɗanda aka haifar da su ta hanyar hydrochlorothiazide. Duk da haka, dukkanin bambance-bambancen guda uku na '' '' Lorist '' suna da lafiya kuma suna da mahimmanci a aikin likita.

Contraindications

Dukkan analogues "Loristas" da "Cosaar", ciki har da "Lozap", umarni (farashin da aka nuna a kasa) ya hana aikace-aikacen a cikin wadannan yanayi:

• A lokacin da ke tasowa wani abu mai rashin lafiyan zuwa duk wani kwayoyi dauke da "Lozartan";

• Yara a karkashin shekara 18 saboda rashin amfani da rashin amfani da illa a cikin wannan rukuni na marasa lafiya;

• A lokacin ciki da lactation.

A cikin marasa lafiya tare da raunin kodan da ke ciki, za'a iya yin amfani da miyagun ƙwayoyi "Lorista", don inganta karamin jini kuma yana da tasiri mai kyau. Har ila yau, "Losartan" shi ne m, amma m sakamako: shi accelerates da tukar tumbi da uric acid, fiye da rage gudu ga cigaban exacerbations na gout. Duk da haka, shi ne amfani da hankali a cikin hanta gazawar. Wannan yanayin asibiti yana dauke da ƙetare dangi.

Yanayin Hanya

A kan miyagun ƙwayoyi "Lorista", "Lozap", "Bloktran", "Cosaar", "Vazotens" farashin ya bambanta, amma siffofin aikace-aikace sun kama kama. Musamman ma, ana amfani da miyagun ƙwayoyi sau ɗaya tare da kyakkyawan mataki na kula da karfin jini ko ƙara ƙãrawa a ciki. Idan hauhawar jini yana da karfi tare da hawan hawan, to, ana buƙatar aikace-aikace na "Lozartan" sau biyu. Yana da kyau a koyaushe yin amfani da miyagun ƙwayoyi a lokaci ɗaya, wanda ya inganta matsayi na iko da matsa lamba da kuma alamar cutar da cutar.

Za a iya amfani da miyagun ƙwayoyi "Lorista" ba tare da la'akari da abinci ba, da wankewa tare da yawan ruwa. A lokacin da aka fara yin aiki na farko, antihypertensive ya tasowa hankali, kuma za ta kai tsayi kawai a cikin makonni 1-2. A cikin wannan '' Losartan '' da sauran 'yan kwastan masu karba na angiotensin (ARB) ba su da mahimmanci ga masu hana ACE. Duk da haka, kungiyar ta ARB tana da muhimmin alama - ba shi da wani tasiri a cikin nauyin tari baƙar fata saboda haɗin bradykinin. Bugu da ƙari, ARBs suna nuna rashin samun tasiri na guje wa aikin da aka haramta, wanda ya saba da amfani da masu amfani da ACE.

Forms of release

"Lorista" an samar da shi a cikin Allunan da ke da harsashi mai zurfi. Dosages an ƙaddara ta hanyar taro na "Losartan" yanzu a cikin kwamfutar hannu daya. Akwai nau'o'i uku na asali na '' Lorist '': 12.5, 25, 100 MG. Har ila yau, a karkashin wannan sunan kasuwancin ya samu kuma haɗuwa tare da ƙunshi abubuwa biyu masu aiki "Lozartan" da "Hydrochlorothiazide", sun haɗu tare da juna. Suna samuwa a cikin wadannan bayanan:

• 100 MG na losartan + 12.5 MG na hydrochlorothiazide - miyagun ƙwayoyi "Lorista H100";

• 50 ML losartan + 12.5 MG hydrochlorothiazide - miyagun ƙwayoyi "Lorista N";

• Mura miliyan 100 na vanartan + 25 MG hydrochlorothiazide - miyagun ƙwayoyi "Lorista ND".

A cikin allunan da ke da irin wannan sashi ana sayar da duk wani analog na "Lorist", yana shiga cibiyar sadarwa.

Farashin "Masu Lissafi"

A kan miyagun ƙwayoyi "Lorista" farashin ya bambanta a wasu yankuna na kasar. Ya dogara da yanayin samarwa da shigarwa zuwa aiwatarwa. Magungunan ko da yaushe mai rahusa a cikin waɗannan birane inda akwai cibiyoyin bincike da gwada kwayoyi. Tunda kowane magungunan, ko da kuwa ko an shigo da shi ko cikin gida, dole ne ya wuce lokacin gwaji na jam'iyyar, to, yana da dabi'a cewa a kasar yana da rahusa a babban birnin. A Moscow, nau'o'i 30 na miyagun ƙwayoyi "Lorista" sune kamar haka:

• "Lorista 12.5 MG" na kimanin 100-150 rubles;

• "Lorista 25 MG" Kudin 160-210 rubles;

• "Lorista 50 MG" yana da tsada 180-270 rubles;

• "Lorista 100 MG" - 270-330 rubles;

• "Lorista N" (50 mg) - 250-300 rubles.

Ana amfani da miyagun ƙwayoyi "Lorista" daga matsa lamba zuwa 30, 60 da 90 allunan. Magunguna waɗanda miyagun ƙwayoyi suke taimakawa kuma suna sarrafa hauhawar jini mai kyau, za ka iya sayen babban kunshin. Wannan shi ne mafi mahimmancin tattalin arziki, saboda ƙididdiga guda uku na alamomin 30 sun ɗauki kashi ɗaya bisa uku fiye da ɗaya kunshin 90 allunan.

Abubuwan da ake amfani da ita na "Loriste"

Kamfanin KRKA yana da daraja ga mai siye, saboda samfurorin da ya samar ya dace da bukatun asibiti. A daidai wannan lokacin, an tabbatar da ingancin su ta hanyar nazarin yanayin rayuwa ga ainihin "Losartan" - "Cosaar". Duk da haka, akwai sauran kwayoyi dauke da "Lozartan". Maganin miyagun ƙwayoyi na "Lorista" da kuma maye gurbin na iya zama mai rahusa. Misalan su ne Vazotens, Bloktran, Prezartan.

Mahimmin analogue mafi mahimmanci shine "Bloktran", wanda ya fi dacewa da mahimmancin siffar sashi, amma yana da irin wannan inganci kamar "Lorista". "Vazotens" yana da tsada fiye da "Bloktran", kodayake kusan iri ɗaya a cikin inganci. Abinda aka zaba a wannan yanayin shine iyawa. Bugu da ƙari, miyagun ƙwayoyi "Bloktran" alamomi suna da alaƙa da waɗanda na kowane analogues dauke da "Lozartan." Wannan abu ne na halitta.

Samfurori na kasuwanci kamar "Lissafi"

Akwai wasu kwayoyi masu dauke da "Losartan" a matsayin abu mai aiki. Sun bambanta a daban-daban farashin da inganci. A wannan yanayin, duk wani nau'i na "Lorist", sai dai don miyagun ƙwayoyi "Cosaar", ƙari ne. "Lorista" shi ma lasisi ne na asalin "Losartan" - magungunan magani "Cosaar". Sabili da haka, a matsayin tushen ma'auni don farashi da inganci, yana da mahimmanci don ɗauka ainihin maganin da kamfanin dillancin labaran kasar MERCK SHARP & DOHME IDEA ya samar. Daga cikin 'yan kasuwa na kasuwanci "Lissafi" akwai shirye-shiryen uku na farashin:

• Tare da farashin mafi girma ("Kozaar", "Amzaar", "Gizaar");

• Tare da kusan wannan farashin ("Lozartan-Teva", "Lozap", "Lorista", "Centor");

• Kwayoyi masu daraja (Lozartan NAN, Lozartan-Richter, Lozartan Belmedpreparaty, Prezartan, Bloktran, Vazotens).

Farashin shirye-shirye na jigon farko ya canza a cikin iyakokin 500-1000 rubles don sakawa a cikin allunan 30 da abun ciki na "Losartan" 100 da 50 MG. Shirye-shirye na hade da 25 ko 12.5 MG na "hydrochlorothiazide" tare da 100 ko 50 MG na "Losartan", bi da bi, farashin kimanin 800-1000 rubles na 30 allunan.

Shirye-shirye na yawan farashin kima daidai yake da farashin "Loriste". Duk wani ma'anar "Lissafin" ya dace a cikin farashin mita 300-600, dangane da sashi da hade tare da "Hydrochlorothiazide". Kuma kwayoyi na farashin farashin kima har zuwa 300 - 400 rubles, wanda ake buƙata don tsari na kowane wata.

Mafi amfani da tattalin arziki ita ce miyagun ƙwayoyi "Lorista", "Centor", "Lozap", "Losartan NAN". Daga cikin hanyoyin da aka fi dacewa su ne mafi kyawun magunguna. Ƙasar da aka fi so ba tare da komai ba daga cikin abubuwan da aka samu na "Losartan" - miyagun ƙwayoyi "Cosaar", wanda shine ainihin. Tare da amfani da shi, an tabbatar da tasiri na "Losartan" a matsayin abu mai mahimmanci.

Kwararrun Masana

Masana sunyi amfani da miyagun ƙwayoyi "Lorista" da kyau, saboda tasirinsa ya tabbatar a binciken nazarin halittun "Kozaaru". Domin an yarda da cewa "Lorista" wani asali ne mai mahimmanci "Cosaar". An samo kyakkyawar amsa daga likitoci saboda rashin tasiri na tserewa daga mataki na haramtawa. Duk da haka, miyagun ƙwayoyi yana da ɓarna a cikin dukkanin ɓangaren mai kwakwalwa na angiotensin. Sakamakon su yana da hankali, wanda zai hana fara zubar da hauhawar jini na farko ko kuma amfani da miyagun ƙwayoyi don rikicin.

Mutuwar Bincike

Tare da shigarwa ta atomatik, marasa lafiya suna lura da ƙananan adadin sakamako masu illa, kusan babu bambanta da alamun da aka nuna a cikin umarnin da aka haɗe. Da miyagun ƙwayoyi yana da kyau kuma yana sarrafa karfin jini na yau da kullum, wanda hakan yakan rage yiwuwar crises. Har ila yau, marasa lafiya marasa lafiya sun lura cewa "Lorista" ba zai rage rashin aiki ba, kamar yadda ya faru da masu ƙetare ACE. Bugu da ƙari, "Lorista" an nuna shi a matsayin magani na lafiya da lafiya don hauhawar jini.